Tiny broccoli sprouts could hold promising benefits for people struggling with insulin resistance and high blood sugar, according to a new scientific review exploring the health potential of nutrient-rich micro-greens. Published in the British Journal of Nutrition and highlighted on 29 October 2026, the review examined how natural compounds found in broccoli sprouts and other cruciferous vegetables may influence metabolic health. These young plants contain carotenoids and other bio-active substances, including compounds that can produce sulforaphane, which researchers believe may help regulate inflammation, protect cells from oxidative stress and support insulin sensitivity. Previous small human studies have reported modest improvements in selected blood sugar measurements, particularly among certain people with prediabetes. However, results have not been consistent across studies, and a separate 2026 clinical trial involving patients with type 2 diabetes and chronic kidney disease found no significant improvement in blood sugar control after broccoli sprout extract supplementation. Scientists emphasise that larger, longer-term human trials are needed to establish whether broccoli sprouts offer meaningful benefits in preventing or managing diabetes. Although they are not a replacement for prescribed medication or established dietary treatment, the findings highlight the potential of everyday vegetables to contribute to future nutrition research and healthier eating strategies.
From the Medical Directory library. For advice about your own health, speak to your healthcare professional.
JOIN THE CONVERSATION
No comments yet. Add a thoughtful question or comment about this article.